Double-blind comparison of etanercept and sulfasalazine,alone and combined in patients with active rheumatoid arthritis.

被引:0
|
作者
Combe, BG
Codreanu, C
Fiocco, U
Gaubitz, M
Geusens, PP
Kvien, TK
Pavelka, K
Sambrook, PN
Smolen, JS
Williams, BD
Appel, A
机构
[1] H Lapeyron, Montpellier, France
[2] C Metod Reumat, Bucharest, Romania
[3] Clin Osp, Padua, Italy
[4] Univ Munster, D-4400 Munster, Germany
[5] Limburgs Univ Ctr, Diepenbeek, Belgium
[6] Dia Syk, Oslo, Norway
[7] Inst Rheumatol, Prague, Czech Republic
[8] RNSH, St Leonards, NSW, Australia
[9] Hos Vien, Vienna, Austria
[10] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales
[11] Wyeth Res, Collegeville, PA USA
来源
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S517 / S517
页数:1
相关论文
共 50 条
  • [1] Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison
    Combe, B.
    Codreanu, C.
    Fiocco, U.
    Gaubitz, M.
    Geusens, P. P.
    Kvien, T. K.
    Pavelka, K.
    Sambrook, P. N.
    Smolen, J. S.
    Wajdula, J.
    Fatenejad, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (10) : 1357 - 1362
  • [2] Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patients
    Codreanu, C
    Combe, B
    Fiocco, U
    Gaubitz, M
    Geusens, PP
    Kvien, T
    Pavelka, K
    Sambrook, P
    Smolen, J
    Williams, BD
    Appel, AM
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 145 - 145
  • [3] A 2-year double-blind comparison of etanercept (enbrel®) and sulfasalazine, alone and combined in patients with active rhuematoid arthritis
    Combe, B
    Kvien, TK
    Fatenejad, S
    Wajdula, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S142 - S142
  • [4] Radiographic outcomes of a double-blind study of etanercept and methotrexate, alone and combined, in patients with active rheumatoid arthritis (the Tempo Trial).
    van der Heijde, D
    Klareskog, L
    DeJager, J
    Gough, A
    Kalden, J
    Malaise, M
    Martin-Mola, E
    Pavelka, K
    Sany, J
    Settas, L
    Wajdula, J
    Pedersen, R
    Fatenejad, S
    Sanda, M
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S122 - S122
  • [5] Results of patient-reported outcomes from a double-blind study of etanercept and sulphasalazine, alone and combined, in patients with active rheumatoid arthritis
    Singh, A
    Appel, AM
    Kvien, TK
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 355 - 356
  • [6] Assessment of functional status among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (tempo trial)
    Singh, A
    van der Heijde, D
    Klareskog, L
    Tornero, J
    Gomes, JM
    Radulescu, F
    Pedersen, R
    Wajdula, J
    Fatenejad, S
    Freundlich, B
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 76 - 76
  • [7] Assessment of treatment satisfaction among patients with active rheumatoid arthritis is a double-blind trial of etanercept and methotrexate alone and combined (tempo trial)
    Singh, A
    van der Heijde, D
    Klareskog, L
    Pedersen, R
    Fatenejad, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S695 - S695
  • [8] ASSESSMENT OF FUNCTIONAL STATUS AMONG PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS IN A DOUBLE-BLIND TRIAL OF ETANERCEPT AND METHOTREXATE, ALONE AND COMBINED (TEMPO TRIAL)
    van der Heijde, D.
    Klareskog, L.
    DeJager, J.
    Gough, A.
    Kalden, J.
    Malaise, M.
    Martin Mola, E.
    Pavelka, K.
    Sany, J.
    Settas, L.
    Wajdula, J.
    Fatenejad, S.
    Sanda, M.
    Pedersen, R.
    Singh, A.
    RHEUMATOLOGY, 2004, 43 : 36 - 37
  • [9] Assessment of functional status among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (TEMPO trial)
    van der Heijde, D
    Klareskog, L
    Pedersen, R
    Fatenejad, S
    Singh, A
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S514 - S514
  • [10] Assessment of treatment satisfaction among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (tempo trial)
    Singh, A
    Klareskog, L
    van der Heijde, D
    Pedersen, R
    Wajdula, J
    Fatenejad, S
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 543 - 543